TipRanks
Go Ultimate55% OFF

Andrew John Partridge Insider Profile

4 Followers

Andrew John Partridge, Chief Growth Officer at GRAIL Inc, holds 155.87K shares in GRAIL Inc (Ticker: GRAL), holds 38.36K shares in Turning Point Therapeutics (Ticker: TPTX). Most recently, Andrew John Partridge Sold ― shares of GRAIL Inc on Oct 07, 2026 for an estimated value of $1.15M.

Andrew John Partridge's Trading History

GRAL
GRAIL Inc
Oct 07, 2026Chief Growth OfficerInformative Sell1.15M$22.36M
TPTX
Turning Point Therapeutics
Feb 11, 2022―Uninformative Sell8.02K$2.92M

You May Also Like

Andrew John Partridge insider profile FAQ

What is the percentage of profitable transactions made by Andrew John Partridge?
The percentage of profitable transactions made by Andrew John Partridge is 0%.
What is the average return per transaction made by Andrew John Partridge?
The average return per transaction made by Andrew John Partridge is -52.50%.
What stocks does Andrew John Partridge hold?
Andrew John Partridge holds: GRAL, TPTX stocks.
What was Andrew John Partridge’s latest transaction?
Andrew John Partridge’s latest transaction was an Informative Sell of $1.15M.
What was Andrew John Partridge's most profitable transaction?
Andrew John Partridge’s most profitable transaction was an Informative Sell of GRAL stock on October 7, 2026. The return on the trade was -7.90%.
What is Andrew John Partridge's role in GRAIL Inc?
Andrew John Partridge's role in GRAIL Inc is Chief Growth Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.